Clinical Trials

200 enrolled

DermatologicLymphoid

Dermatitis, Atopic, Eczema, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT06608511 2025-12-17

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

20 enrolled

Carcinoma, Basal Cell, Melanoma, Skin Neoplasms

NCT01334008 2025-11-24

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

40 enrolled

Uveal Melanoma

NCT07148245 2025-11-10

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

300 enrolled

Melanoma

NCT02849145 2025-09-19

ctDNA R0

60 enrolled

Uveal Melanoma

NCT03225365 2025-09-17

IMMUNONIVO

5 enrolled

Melanoma

NCT02626065 2025-09-15

PAIR

Phase 4 Completed

32 enrolled

Melanoma

NCT02831634 2025-09-08

NeoEpitope

25 enrolled

BreastDermatologic

Breast Neoplasms, Melanoma

NCT06605404 2025-08-14

Pan-tumor MRD Study

DermatologicGastrointestinalThoracic

1,350 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma

NCT06382844 2025-05-01

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

DermatologicGenitourinarySarcoma

100 enrolled

DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Terminated

13 enrolled

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

NCT02278887 2025-03-10

TIL

Phase 3 Completed

168 enrolled

Melanoma

NCT05940311 2024-11-27

VerSiLiB

20 enrolled

Melanoma

NCT02875652 2024-01-31

ctDNA MU

800 enrolled

Uveal Melanoma

NCT05029791 2023-12-15

COLEMAN

Phase NA Recruiting

100 enrolled

Melanoma

NCT03267381 2023-12-14

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

37 enrolled

Melanoma

NCT02977052 2023-11-15

OpACIN-neo

Phase 2 Unknown

186 enrolled

Melanoma

NCT03416933 2023-08-04

OPTIMEL

35 enrolled

Melanoma

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Phase 4 Unknown

50 enrolled

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT05817149 2023-04-18

Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

20 enrolled

Phase 4 Active not recruiting

Melanoma

NCT02068196 2023-03-24

Ipi4

150 enrolled

Melanoma, Neoplasms

NCT02414750 2022-11-30

REPOSIT

Phase 2 Terminated

78 enrolled

Melanoma

NCT05062096 2022-10-04

NAKIMEL

Phase NA Unknown

220 enrolled

Melanoma

NCT00507325 2022-09-02

Sample Collection From Melanoma Patients

Terminated

131 enrolled

DermatologicGenitourinaryThoracic

Melanoma, Neoplasms

NCT05426317 2022-06-22

Onco-PDL1s/B2M

Phase NA Unknown

100 enrolled

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma

NCT02907086 2022-06-06

Circulating Tumor Material in Colorectal Cancer and Melanoma

DermatologicGastrointestinal

7 enrolled

Melanoma, Colorectal Neoplasms

NCT04154163 2022-02-28

ADOPT

DermatologicGenitourinaryGynecologicThoracic

18 enrolled

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma, Ovarian Neoplasms

NCT00793169 2021-12-06

Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery